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Abstract
Background: Pandemic influenza A (H1N1) disproportionately affects different age groups. The purpose of the
current study was to describe the age and gender difference of pandemic influenza A (H1N1) cases that lead to
pneumonia, hospitalization or ICU admission.
Methods: Data were collected retrospectively between May 2009 and December 2009. All of the diagnoses of
H1N1 were confirmed by real-time reverse-transcription polymerase chain reaction (RT-PCR).
Results: During the study period there were 3402 cases of RT-PCR positive H1N1, among which 1812 were males
and 1626 were adults (> 15 years of age). 6% (206/3402) of patients required hospitalization, 3.6% (122/3402) had
infiltrates on chest radiographs, and 0.70% (24/3402) were admitted to intensive care unit (ICU). The overall fatality
rate was 0.1% (4/3402). The rate of hospitalization was sharply increased in patients ≥ 50 years of age especially in
male. Out of 122 pneumonia patients, 68.8% (84 patients) were male. Among the patients admitted to the ICU,
70.8% (17 patients) were male. Approximately 1 of 10 H1N1-infected patients admitted to the ICU were ≥ 70 years
of age.
Conclusions: Among the confirmed cases of H1N1, the ICU admission rate was < 1% and the case fatality rate
was 0.1%. Male had a significantly higher rate of pneumonia and hospital admission. These findings should be
taken into consideration when developing vaccination and treatment strategies.
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Background
The rates of illness from H1N1 virus infection may have
variation in relation to geographic variation. During one
outbreak in New Zealand, the attack rate of illness was
estimated to be 7.5%, and the attack rate of the overall
infection was estimated at 11% [1]. The overall case
fatality rate has been reported to be < 0.5% [2,3]. The
case fatality rate for symptomatic illness has been esti-
mated to be 0.048% in the United States [4] and 0.026%
in the United Kingdom [5].
The rates of hospitalization and death have varied
widely according to country [6]. In one study, the hospi-
talization rates have been highest for children < 5 years
of age, especially those < 1 year of age, and lowest for
persons ≥ 65 years of age [7]. In the United States,
among patients who were hospitalized with pandemic
influenza, 32%-45% were < 18 years of age [7,8].
Approximately 9%-31% of hospitalized patients have
been admitted to an intensive care unit (ICU), where
14%-46% of patients die [7-11]. The overall case fatality
rate among hospitalized patients appears to be highest
among those ≥ 50 years of age and lowest among chil-
dren [5,7,11,12].
Studying the case fatality rate, hospitalization cases,
pneumonia cases, and ICU cases in relation to age and
gender are important for estimating the disease burden
and understanding the background of H1N1 virus infec-
tions, which in turn may affect treatment and preven-
tion strategies. There is paucity of description of gender
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sion in pandemic influenza A (H1N1) 2009.
In the present study, we aimed to describe the age and
gender difference of pandemic influenza A (H1N1) cases
that lead to pneumonia, hospitalization or ICU
admission.
Methods
Keimyung University Dongsan Hospital (KUDH)
KUDH is a 931 bed tertiary care hospital that also
serves as an urban general hospital in Daegu City, South
Korea. KUDH serves as a referring hospital an area of
about 500,000 inhabitants.
Collection of specimen
Sterile swabs with cotton tips and wooden shafts were
inserted into the oral cavity of the patients. The throat
swab was rubbed on the peri-tonsillar surface or the
pharyngeal mucosa. The swab was removed and stored
in a bottle containing 1 ml of virus transport media.
Real time RT-PCR assay
RNA was extracted using the Abbott sample preparation
system. Viral RNA was reverse-transcribed into comple-
mentary DNA (cDNA) using a swine-lineage influenza A
(H1N1) generic primer. The subsequent PCR amplification
and real-time detection of cDNA was performed on an
Abbott m2000rt amplification machine. Each RNA extract
sample was tested by the following separate primer/probe
sets: InfA; Universal swine (swFluA); Swine H1 (swH1);
and RNaseP (RP). The RNaseP primer and probe set tar-
gets the human RNaseP gene and thus serves as an internal
positive control for human nucleic acid. The test for H1N1
virus was regarded positive if the specimen was positive for
the swFluA or swH1 probe, with a concomitant positive
reaction to the InfA and RNaseP (RP) probes [13].
Definition
We defined the symptomatic of influenza as a patient
with fever and/or respiratory symptoms and/or general-
ized symptoms of infection, such as myalgia, headache
and chills. We defined fever as a temperature > 38°C.
We used Tympanic Electronic Thermometers. The defi-
nition of H1N1-associated pneumonia was as follows: 1)
symptoms consistent with an influenza-like illness; 2)
positive test for real time RT-PCR or RT-PCR; and 3)
presence of pneumonic infiltration on simple chest
radiography at the time of initial evaluation. There were
no strict criteria for general ward or intensive care unit
(ICU) admission, but in general patients presenting with
several positive SIRS criteria such as heart rate > 100,
respiratory rate > 25, and fever > 38°C were admitted to
the general ward. Patients had severe hypoxemia or
hemodynamic instability were referred to the ICU.
Data collection
Our study was approved by the Institutional Review
Board at Dongsan Hospital of the Keimyung University
School of Medicine. Data were extracted from compu-
ter-based records of symptomatic patients who were
cared for at our hospital due to viral illnesses between
1 May and 31 December 2009. During the study per-
iod, our hospital opened specialized H1N1 clinics
which were able to assess every patient who had symp-
toms without the need for referral to other health care
facilities. We reviewed all of the medical records of
patients with a discharge diagnosis of H1N1 virus
infection.
Statistical Analysis
The rate of H1N1 admission or pneumonia was calcu-
lated as the number of admissions or pneumonias per
100 symptomatic H1N1 virus-confirmed patients.
Ninety-five percent confidence intervals (CIs) were cal-
culated using the normal approximation to the bino-
mial distribution. A c
2 test was used to compare




Between 1 May and 31 December 2009, 3402 sympto-
matic pandemic influenza A (H1N1) cases were con-
firmed out of 11,114 real time RT-PCR tested cases.
Among the cases, 1812 (53%) were male and 1590 (47%)
were female (Table 1). The median age of all cases was
14 years (range, 1-84 years). After November 1, H1N1
confirmed cases were declined (Figure 1).
Table 1 Number of Symptomatic Pandemic 2009
Influenza A(H1N1), Hospitalized, Pneumonia, and ICU




Hospitalized Pneumonia Intensive Care
Unit
Age Male Female Male Female Male Female Male Female
0-4 192 180 27 10 14 6 2 2
5-9 432 311 43 16 33 9 3 0
10-14 373 288 12 6 10 2
15-19 442 267 936311
20-29 175 219 3 10 1 3
30-39 85 145 251201
40-49 53 69 754421
50-59 37 58 897430
60-69 15 30 995231
70-79 7 15 562221
8 0 - 18111110
1812 1590 126 80 84 38 17 7
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The rate of admission was 206 of 3,402 patients (6.05%;
95% CI, 5.3-6.9). The median age of the admitted
patients was 14 years (range, 1 - 84 years) and 126 of
the patients (61%) were male (P < 0.001) (Table 2).
Although the number of hospitalizations (n = 59) was
highest in the patients 5-9 years of age, the admission
rate was 8% among symptomatic H1N1 patients of the
same age. The rate of hospitalization was sharply
increased in the patients > 50 years of age (Figure 2)
especially in male (Figure 3). Eleven of 22 symptomatic
patients (50%) with H1N1 who were admitted to the
hospital were ≥ 70 years of age. However, in infants < 1
year and < 1 month of age, the hospitalization rate per
100 symptomatic H1N1 cases was 24% (n = 11) and
82% (n = 9), respectively.
H1N1-associated Pneumonia
122 patients (3.6%; 95% CI, 3.0 - 4.2) were diagnosed
with H1N1-associated pneumonia among 3402 sympto-
m a t i cH 1 N 1p a t i e n t s .T h em e d i a na g eo ft h ep a t i e n t s
with pneumonia was 9.5 years (range, 1 - 84 years) and
84 of the patients (68.8%) were male (P < 0.01) (Table 1,
2). 25 patients (33.7%) reported having asthma among
74 admitted patients < 15 years of age. Ten adult
patients (20.8%) who were admitted had asthma or
COPD. Although the number of hospitalizations (n =
42) was highest in the patients 5-9 years of age, the rate
of pneumonia was sharply increased in symptomatic
patients with H1N1 who were > 50 years of age
(Figure 4) especially in male (Figure 3).
ICU admission
Twenty-four patients (0.7%; 95% CI, 0.47 - 0.10) with
symptomatic H1N1 infections were admitted to the
ICU, and 5 required mechanical ventilation. The median
age of the patients admitted to the ICU was 47 years
(range, 1 - 84 years) and 17 (70.8%) were male (P <
0.05). Ten percent of symptomatic patients with H1N1
admitted to the ICU were ≥ 70 years of age. There were
Figure 1 Symptomatic Patients with Pandemic Influenza A(H1N1) (n = 3,402) Between May 1, 2009 and December 31, 2009.
Table 2 Comparison of admission and pneumonia
between male and female in Pandemic 2009 Influenza A
(H1N1) confirmed cases





Admission 126 80 < 0.001
Pneumonia 84 38 0.006
ICU admission 17 7 0.82
Figure 2 Number (n = 206) and rate (6.05%) of hospitalizations
due to pandemic influenza A (H1N1) infection by age groups
among confirmed symptomatic patients.
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I C U( F i g u r e5 ) .O ft h e2 0 6p a t i e n t sw h ow e r eh o s p i t a -
lized, 201 (97.5%) received antiviral treatment, and 180
(87%) received treatment within 48 hours of the onset
of symptoms. We found no significant differences in the
rate of ICU admission between male and female.
Case Fatality
Four of 3402 symptomatic patients with H1N1 (0.11%)
died. All of the patient deaths were ≥ 40 years of age.
The mean time from hospital admission to initiation of
antiviral treatment was 1.2 days (range, 0-24 days). We
found no significant differences in the rate of deaths
between male and female.
Discussion
In the present study, the hospitalization rate, rate of
pneumonia, ICU admission rate, and case fatality rate
among patients with confirmed symptomatic pandemic
influenza A (H1N1) were 6%, 3.6%, 0.7%, and 0.1%,
respectively.
Rate of hospital/ICU admission and pneumonia in
male were about 2 times higher than female especially
in the more than 50 years-old pandemic influenza A
(H1N1) 2009 confirmed cases. There was also higher
rate of ICU admission in male, while statistics did not
reach to meaningful. Different behavior, hormone
responses, and susceptibility to infectious disease may
lead to distinct profiles of pandemic influenza A(H1N1)
2009-associated morbidity for male and female.
The severity of infection may be measured in a variety
of ways; the case-fatality rate, which is the probability
that an infection causes death, is the simplest method
by which to measure the severity of infection. The case-
fatality rate may be influenced by the denominator (the
non-fatal patients). Asymptomatic H1N1 virus infections
or patients with mild disease were often thought to have
a simple cold, and therefore overlooked (undiagnosed).
Therefore, diagnostic strategies of the H1N1 virus may
have a big influence on the overall fatality rate. The
severity of infection may be measured based on the hos-
pitalization cases and ICU cases (the probabilities that
an infection leads to hospitalization or ICU admission).
The age-specific severity patterns, as estimated herein,
a r ed i f f e r e n tf r o mt h ea g e - s p e c i f i cs e v e r i t yp a t t e r n s
which would be obtained by simply comparing the
Figure 3 Rate of hospital admission (A) and pneumonia (B) per
100 pandemic influenza A (H1N1)-confirmed cases. Results for
both male and female are shown separately for those aged < 50
years old and those aged ≥ 50 years old. Comparisons were made
of the rate of hospital admission (*P < 0.001) and pneumonia (
†P =
0.0019) between male and female aged ≥ 50. There was a
significant difference of the rate of admission between aged < 50
years old and aged ≥ 50 years old in both sexes (
‡P < 0.001).
Figure 4 Number (n = 122) and rate (3.58%) of pneumonia in
pandemic influenza A (H1N1)-confirmed patients by age group.
Figure 5 Number (n = 24) and rate (0.70%) of ICU admissions
in pandemic influenza A (H1N1)-confirmed patients by age
group.
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as a whole for a similar period of time [7,14].
The estimation of the case fatality rate using the
laboratory-confirmed cases in the denominator resulted
in a rate of 0.82%. This finding is consistent with other
studies that have used laboratory-confirmed cases as a
denominator [15,16]. The early epidemiologic features
of mortality from the pandemic H1N1 infection were
different in relation to the region, and the majority of
H1N1 virus infection-related deaths occurred in patients
20-49 years of age [15]. The calculated case-fatality rate
in Asian countries is lower than on the other continents
[15]. The case-fatality rate may have been influenced by
the denominator (the non-fatal patients). The mortality
rate for symptomatic illness was estimated to be 0.048%
in the United States [4] and 0.026% in the United King-
dom [5].
In the present study, the denominator was confirmed
symptomatic patients with H1N1; the overall mortality
was 0.1%, which was comparable to previous studies [4].
However, the mortality of elderly patients infected with
pandemic H1N1 is higher in Asian countries [15]. The
elderly appear to be less infected from pandemic influ-
enza A (H1N1), which may be due to a lack of expo-
sure. However, when infected, the elderly are more
likely to have a fatal outcome than younger patients
[17].
The first pandemic influenza A (H1N1) virus-infected
patient in the US was confirmed on 15 April 2009 [18].
Although the first H1N1 patient was confirmed in May
2009, a surge in the number of infected patients was
observed 5 months later (October 2009) in KUDH (Fig-
ure 1). National H1N1 influenza vaccination program in
Korea has started for medical personnel on October 27,
and extended in general population on November 1. At
the same time with vaccination program has started,
H1N1 confirmed cases were declined.
We can confirm all of the H1N1 cases by RT-PCR
without delay, even on holidays, and suspected H1N1
cases are treated with oseltamivir before the RT-PCR
results are available. These efforts could change the epi-
demiologic features. The mean time from hospital
admission to initiation of antiviral treatment was 1.5
days in the present study, which was more rapid than a
previous study [7].
Conclusion
Among the H1N1-confirmed cases, ICU admissions
occurred in < 1% of patients and the case-fatality rate
was 0.1%. The rate of pneumonia and ICU admissions
in males ≥ 50 years of age have sharply risen. Males had
a significantly higher rate of pneumonia and hospital
admission especially ≥ 50 years of age. In the present
study, the male predominance in relation to rate of
admission and pneumonia should be taken into consid-
eration when developing vaccination strategies and
empirical treatments are used.
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